Colony Group LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Colony Group LLC
- $6.66 Billion
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
51Shares Held
7.83MCall Options Held
628KPut Options Held
338K-
Israel Englander Millennium Management LLC | New York, Ny1.8MShares$2.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$1.94 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.36MShares$1.91 Million0.03% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.06MShares$1.48 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT514KShares$719,9820.13% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $28.6M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...